US President Trump Writes to 17 Pharmaceutical CEOs for Drug Price Cut

• President Donald Trump has written to 17 top pharmaceutical CEOs, including Vasant Narasimhan, MD and CEO of Novartis, demanding an urgent action to reduce US drug prices.

• The letters, signed by the President and disclosed at a White House briefing, give companies until September 29, 2025, to commit to offering Americans the same prices they charge in Europe and other developed nations.

• The announcement marks a significant escalation in the administration’s war on “abusive drug pricing practices.”

• The letters include four binding demands: extend global parity pricing to Medicaid, apply fair pricing to new drugs, redirect overseas profits to American patients, and enable direct consumer purchases at internationally benchmarked prices.

• The letters echoe the urgent message that the days of global freeloading on American innovation are over.

• The White House warns companies that if they fail to comply, the White House will deploy every tool in its arsenal.